Frazier Life Sciences Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-300,000
| Closed | -$5.69M | – | 52 |
|
|
2023
Q2 | $5.69M | Sell |
300,000
-285,759
| -49% | -$5.42M | 0.34% | 39 |
|
|
2023
Q1 | $9.09M | Hold |
585,759
| – | – | 0.66% | 31 |
|
|
2022
Q4 | $10.4M | Hold |
585,759
| – | – | 0.65% | 30 |
|
|
2022
Q3 | $3.27M | Hold |
585,759
| – | – | 0.25% | 37 |
|
|
2022
Q2 | $2.28M | Hold |
585,759
| – | – | 0.22% | 35 |
|
|
2022
Q1 | $3.23M | Buy |
+585,759
| New | +$3.23M | 0.28% | 38 |
|